Janney Recent News
Waters Has Limited Upside Potential To Growth Expectations; Janney Steps to The Sidelines
Janney: 4 Reasons Why Selecta Biosciences Is 'Significantly Undervalued'
Summit Therapeutics' Upcoming Duchenne Muscular Dystrophy Data 'A Strong Catalyst,' Janney Says In Bullish Initiation
Janney Upgrades American Water Works After Pivotal Acquisition: 'The Upside Potential Outweighs Downside Risk'
Janney: Buy The Dip In Uniqure
Janney Says Bluebird's Therapies Are 'Encouraging,' But Stock Is Fairly Valued
Janney Cites CDM Acquisition In Bullish Stance On USA Compression Partners
Strong Outlook, Pullback On Shares Lead Janney To Upgrade RGC Resources
First Solar's Outlook Dims After Q3 Results
Agree Realty Gets The Nod Of Approval From Janney
CONE Midstream Initiated At Buy From Janney On Attractive Valuation
Janney Initiates Galapagos At Buy, Sees Fair Value Of Shares At $64
Janney Initiates Jazz Pharma At Neutral, Cites Potential Competition For 'Blockbuster Narcolepsy Franchise'
Downside Risk In Sarepta Shares Greater Than Upside Potential, Janney Says
Sum-Of-The-Parts Analysis On Chesapeake Utilities Leads Janney To Upgrade Stock
First Solar Bulls Get Burned Following Q2 Beat
Janney Analyst Raises Genesis Energy's Fair Value Estimate, Cites Increased Execution Confidence
CareDx Reported Positive Clinical Results For Its Kidney Transplant Blood Tests
Cynapsus Therapeutics Developing New Parkinson's Treatment That Won't Require Injection
Janney Upgrades Equity Residential
Janney: Time To Buy Boyd Gaming Ahead Of Las Vegas And Atlantic City Strength
Janney Upgrades Amicus, Says EU Approval 'Likely'
Janney: Time To Buy Acceleron